PCOS Hormone Check

An 8-biomarker panel targeting the androgen levels and reproductive hormones involved in polycystic ovary syndrome. Measures the hormonal patterns that characterise PCOS, helping women who suspect the condition or want to monitor diagnosed PCOS.

Polycystic ovary syndrome affects an estimated 8-13% of Australian women of reproductive age, yet many remain undiagnosed for years. This targeted panel measures the hormonal markers most relevant to PCOS diagnosis and monitoring — elevated androgens (the hallmark of PCOS), disrupted gonadotropin ratios (LH:FSH), and markers of metabolic dysfunction that commonly accompany the condition. The androgen assessment reveals whether symptoms like acne, hirsutism, hair thinning, and irregular periods have a hormonal basis. The LH:FSH ratio provides insight into ovulatory function — in PCOS, LH is typically elevated relative to FSH, which disrupts follicular development and ovulation. This panel can be used as an initial screening tool for women who suspect PCOS based on symptoms, or as a monitoring tool for those already diagnosed who want to track their hormonal response to lifestyle changes, medications, or supplements. Results should be interpreted alongside clinical symptoms and, where available, ultrasound findings.